Abstract

BackgroundLiver cancer is one of the most common malignancies in the world with a poor prognosis. Hepatocellular carcinoma (HCC) is the most prevalent primary liver cancer, accounting for 80–90% of cases. The initiation and progression of HCC are closely associated with chronic liver inflammation. In addition, HCC is often accompanied by cell senescence. Senescent hepatocytes can secrete various inflammatory factors, collectively called the senescence-associated secretory phenotype (SASP). The SASP has been confirmed to promote the occurrence of liver cancer by affecting the inflammatory microenvironment. However, its role and the underlying mechanism of hepatic SASP in hepatocarcinogenesis are not clearly understood. Therefore, a better understanding of the pathogenic mechanisms of the effect of the hepatic SASP on the occurrence of HCC is still needed.MethodsThe study aims to explore the role of SASP factors and the underlying mechanism in tumorigenesis and the progression of HCC in vivo. We used diethylnitrosamine (DEN) combined with carbon tetrachloride (CCl4) (DEN-CCl4) to establish liver cancer model in wild-type (WT) mice and Bcl3 knockout (Bcl3−/−) mice. β-galactosidase (β-gal) staining was performed to evaluate the degree of cellular senescence. Immunohistochemistry (IHC) were used to detect the degree of cellular senescence and the activation of macrophage. PCR chip and clinical tissue chip assays were used to estimate the RNA levels of SASP factors and NF-κB related genes, and their protein levels were examined by Western blot assays.ResultsDEN-CCl4 induced cellular senescence in mouse hepatocytes. In addition, senescent hepatocytes might release a variety of inflammatory factors that further activate macrophages, thereby changing the microenvironmental state and promoting the occurrence of HCC. Mechanistically, the NF-κB pathway is important because it regulates the SASP. Therefore, we used a PCR chip to detect the expression of NF-κB-related genes in senescent liver tissue. Our results showed that the expression of Bcl3 was increased in senescent hepatocytes, and knocking out Bcl3 significantly inhibited the secretion of hepatocyte SASP factors and the activation of macrophages, thereby inhibiting hepatocarcinogenesis. Finally, in clinical tissues adjacent to HCC tissues in patients, the expression of Bcl3 and IL-8 correlated with poor prognosis in HCC patients.ConclusionThe hepatic SASP can further induce the activation of macrophages during hepatocarcinogenesis, thereby promoting the occurrence of HCC, and that this process is closely related to the expression of Bcl3 in hepatocytes.

Highlights

  • Liver cancer is the sixth most commonly diagnosed cancer and the third leading cause of cancer-related death worldwide, and it is mainly categorized into primary liver cancer and metastatic liver cancer [1]

  • The hepatic senescenceassociated secretory phenotype (SASP) can further induce the activation of macrophages during hepatocarcinogenesis, thereby promoting the occurrence of Hepatocellular carcinoma (HCC), and that this process is closely related to the expression of B-cell leukemia 3 (Bcl3) in hepatocytes

  • The hepatic senescence‐associated secretory phenotype increases during hepatocarcinogenesis in mice We explored the role of senescent hepatocytes in hepatocarcinogenesis using the well-established N-nitrosodiethylamine (DEN)- and carbon tetrachloride ­(CCl4) (DEN-Carbon tetrachloride (CCl4))-induced HCC mouse model (Fig. 1a, b)

Read more

Summary

Introduction

Liver cancer is the sixth most commonly diagnosed cancer and the third leading cause of cancer-related death worldwide, and it is mainly categorized into primary liver cancer and metastatic liver cancer [1]. Hepatocellular carcinoma (HCC) is the most prevalent primary liver cancer [2]. The exact role and underlying mechanism of the inflammatory microenvironment in hepatocarcinogenesis remain controversial. Hepatocytes are the majority of the hepatic cells in liver. Few studies were focused on the contribution of hepatocytes to inflammatory microenvironment and their role in hepatocarcinogenesis [6]. Hepatocellular carcinoma (HCC) is the most prevalent primary liver cancer, accounting for 80–90% of cases. The SASP has been confirmed to promote the occurrence of liver cancer by affecting the inflammatory microenvironment. Its role and the underlying mechanism of hepatic SASP in hepatocarcinogenesis are not clearly understood. A better understanding of the pathogenic mechanisms of the effect of the hepatic SASP on the occurrence of HCC is still needed

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call